> 资讯
CAPHRA Urges Policymakers to Expand the Tobacco Cessation Toolkit
2026-05-04 资讯 Coalition of Asia Pacific Tobacco Harm Reduction Advocates
MANILA, Philippines, May 04, 2026 (GLOBE NEWSWIRE) -- CAPHRA is calling for a more comprehensive, evidence-based approach to tobacco cessation and harm reduction — one that acknowledges the full range of risks faced by smokers and oral tobacco users worldwide, and the diverse ways adults successfully move away from deadly products that includes safer nicotine options for adults.
What Are Safer Nicotine Options for Adults Who Smoke?
Safer nicotine options are regulated products that do not involve burning tobacco and are manufactured under clear safety and quality standards. They include NRT (nicotine replacement treatments) as well as regulated nicotine products.
A full toolkit of regulated, lower-risk alternatives drives the outcomes that matter most: fewer people using cigarettes and dangerous oral tobacco products, fewer preventable deaths, lower health system costs, and faster population-level progress.
This is not a question of ideology or product preference. It is a question of measurable impact.
Why a Broader "Toolkit" Delivers Better Public Health Outcomes
People do not quit tobacco in the same way. Some switch quickly; others move gradually. Cultural context, product preference, and individual circumstances all shape the transition. Restricting policy to a single cessation pathway limits reach and slows progress — not because people lack motivation, but because the system offers too few options.
The public health objective is straightforward: real choice for adults who smoke, robust product standards, and controlled access under firm rules.
Read more here: https://bit.ly/4sVAfS6
Media Contact:
N.E. Loucas
Executive Coordinator CAPHRA
neloucas@caphraorg.net
- 搜索
-
- 05-04香港国际机场黄金周购物赏
- 05-04《任玉岭传奇》150篇连载(三)公差坐“二等”少知少见
- 05-04浓情澳门2026|沪澳相遇,一城烟火藏双城风情
- 05-04西岸中環二期商业正式启幕,以生活方式美学升级徐汇滨江商业体验
- 05-04五一趣游福州 鼓山鼓岭双景齐出彩
- 05-04共青城市“青年说”理论宣讲首场巡讲开讲 青春之声进高校迎五四
- 05-04中国科学家发现激活GHSR-1α受体是保持年轻健康关键
- 05-04Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate
- 05-04CAPHRA Urges Policymakers to Expand the Tobacco Cessation Toolkit
- 05-03笔墨走太行 丹青写丘壑——张新军郭亮村写生创作纪实